[{"Assets_0_Q3_USD":270834000.0,"CommonStockSharesOutstanding_0_Q3_shares":97425721.0,"NetCashProvidedByUsedInOperatingActivities_3_Q3_USD":-69700000.0,"NetIncomeLoss_1_Q3_USD":-33830000.0,"NetIncomeLoss_3_Q3_USD":-91005000.0,"StockholdersEquity_0_Q3_USD":254160000.0,"Ticker":"IOVA","CIK":"1425205","name":"IOVANCE BIOTHERAPEUTICS, INC.","OfficialName":"Iovance Biotherapeutics Inc. Common Stock","form":"10-Q","period":"20180930","fy":"2018.0","fp":"Q3","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"2593277297.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20181106"}]